Ambisol Pharma Private Limited
About Ambisol Pharma Private Limited
Data last updated:
Ambisol Pharma Private Limited is a private limited company based in Govandi, Maharashtra, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 19 December 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51502MH2014PTC260272. Its GSTIN is 27AANCA0926F1ZS (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Abdhesh Ganesh Laldas and Anjana Amit Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Govandi, Maharashtra.
As per the financials filed for FY 2017, the company reported a revenue of ₹21.61 Lakh. For the same year it recorded a net loss of ₹38,011 (net margin -1.8%) and EBITDA of -₹36,465 (EBITDA margin -1.7%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address601 Sai Samarth Commercial Premises Co – Op Society Near Wasan Motor Deonar Village Road. D, Eonar, Govandi, Maharashtra, India – 400088
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Ambisol Pharma Private Limited FY 2025 filings available
Ambisol Pharma Private Limited reported revenue of ₹21.61 Lakh for FY 2017.
Financial Statement Summary of Ambisol Pharma Private Limited
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹21.61 Lakh | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | -₹36,465 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹38,011 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Ambisol Pharma Private Limited
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -1.7% | •••• | •••• |
| Net Profit Margin | -1.8% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ambisol Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Ambisol Pharma Private Limited
Ambisol Pharma Private Limited is audited by C P PANDEY & CO for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| C P PANDEY & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ambisol Pharma Private Limited
Ambisol Pharma has 2 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abdhesh Ganesh Laldas Also directs: RNCK Multiprojects Limited, Yeppeo Aesthetic Private Limited, Yeppeo Gold Private Limited and 5 more | Director | 01 Sep 2020 | 6 Years 1 Months | Current |
| Anjana Amit Mishra | Director | 07 Sep 2020 | 6 Years 1 Months | Current |
Ownership and Shareholding of Ambisol Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ambisol Pharma Private Limited
Ambisol Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ambisol Pharma Private Limited
Employment history and EPFO contributions of people linked to Ambisol Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ambisol Pharma Private Limited
Ambisol Pharma Private Limited has 12 board changes on record since 2015: 2 appointments and 10 cessations. The latest: Pravesh Kamat ceased to be Director on 14 May 2024.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Ambisol Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ambisol Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ambisol Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ambisol Pharma Private Limited
Ambisol Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AANCA0926F1ZS | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ambisol Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ambisol Pharma Private Limited
Ambisol Pharma is an active private limited company based in Govandi, Maharashtra, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 19 December 2014 (12+ years old) and is registered under CIN U51502MH2014PTC260272.
Ambisol Pharma reported revenue of ₹21.61 Lakh for FY 2017.
Ambisol Pharma has 2 current directors:
- Abdhesh Ganesh Laldas - Director
- Anjana Amit Mishra - Director
Ambisol Pharma reported a net loss of ₹38,011 (net margin -1.8%) and EBITDA of -₹36,465 (EBITDA margin -1.7%) for FY 2017, as per its filed financial statements.
The GSTIN of Ambisol Pharma is 27AANCA0926F1ZS, registered in Maharashtra.
The CIN (Corporate Identification Number) of Ambisol Pharma is U51502MH2014PTC260272. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ambisol Pharma was incorporated on 19 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
Pravesh Kamat ceased to be Director on 14 May 2024. Simran Hariya Karmali ceased to be Director on 24 Jun 2021. Anjana Amit Mishra was appointed as Director on 07 Sep 2020. Ambisol Pharma has 12 board changes on record in total.
The registered office of Ambisol Pharma is at 601 Sai Samarth Commercial Premises Co – Op Society Near Wasan Motor Deonar Village Road. D, Eonar, Govandi, Maharashtra, India – 400088.
Ambisol Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.